Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSaglik Bilimleri Universitesi
About this trial
Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study.
Data will be compared in terms of ECHO and ECG findings depending on hyperkalemia level and response to treatment.
Eligibility criteria
Qualifiers
Patients over 18 years old
Chronic kidney disease patients with eGFR < 60 mL/min/1.73 m²
Patients with hyperkalemia detected in the emergency department
Patients willing to participate in the study and who sign the consent form
Disqualifiers
Patients under 18 years old
Patients who do not wish to participate in the study
Patients without chronic kidney damage
Patients without detected hyperkalemia
Trial design
Treatments tested in this trial
- Not listed
Trial groups
40 Participants
are grouped into 1 trial groupLocations
1Etlik City Hospital06170, Ankara Turkey (Türkiye)
Sponsors and collaborators
Saglik Bilimleri Universitesi
Lead sponsor
Source ClinicalTrials.gov